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ABSTRACT  
Symptoms of opiate withdrawal include disturbances in circadian rhythms.  Here, 
we examined in male Wistar rats the effects of a daily, mid-morning morphine injection 
(5-40mg/kg, i.p.) and the subsequent withdrawal of morphine on 24-h patterns of wheel 
running and expression of the clock protein, PERIOD2 (PER2), in the master circadian 
clock, the suprachiasmatic nucleus (SCN), and regions of the limbic forebrain. Rats 
were killed either within 24 h of the last morphine injection or 2 days later.  Nighttime 
wheel running was suppressed during daily morphine injections and following the 
withdrawal of morphine. Daily morphine injections and their subsequent withdrawal did 
not affect PER2 expression in the SCN, but blunted the normal daily peak of PER2 in 
the dorsal striatum, oval nucleus of the bed nucleus of the stria terminalis (BNSTov), 
central nucleus of the amygdala (CEA), basolateral amygdala (BLA), and dentate gyrus 
of the hippocampus (DG).  We then examined the effect of injecting the D2/3 dopamine 
agonist, quinpirole (1 mg/kg, i.p.), or the alpha 2 adrenergic agonist, clonidine (0.1 
mg/kg, i.p.), two drugs that alleviate opiate withdrawal symptoms, following withdrawal 
of the daily morphine injection.  Quinpirole restored the daily PER2 pattern in the 
BNSTov and CEA, whereas clonidine restored and entrained a new PER2 pattern in the 
striatum, BLA, and DG. Together, these findings suggest that disruption of daily PER2 
patterns in the forebrain might contribute to the circadian symptoms observed in opiate 
withdrawal.  Furthermore, pharmacological treatments for withdrawal can restore PER2 
patterns in regions of the limbic forebrain.   
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INTRODUCTION 
Opiate withdrawal is characterized by profound physiological and motivational 
deficits that include disturbances in circadian rhythms of activity and hormone secretion 
(Li et al, 2009a; Li et al, 2009b).  Disruptions in sleeping and diurnal activity patterns are 
common symptoms reported in humans undergoing withdrawal and are thought to 
contribute to increased risk of relapse (Howe et al, 1980; Shi et al, 2007; Stinus et al, 
1998).  
At the molecular level, circadian timing relies on a group of clock genes that 
regulate their own transcription and translation through negative and positive feedback 
loops (Reppert and Weaver, 2002). The master circadian clock in mammals is housed 
in the suprachiasmatic nucleus (SCN) of the hypothalamus and light is the primary 
stimulus to entrain the timing of the molecular clockwork in the SCN. Clock genes are 
also rhythmically expressed in a number of other brain regions and peripheral tissues, 
although synchronizing signals from the SCN are required to maintain and coordinate 
rhythmic activity across tissues.  It is believed that these local rhythms regulate the daily 
variations in cellular and metabolic functions of individual tissues.   
In addition to light, a variety of non-photic stimuli, including events having 
motivational salience, can entrain the rhythms of clock gene expression in other tissues 
independently of the SCN.  These stimuli include the presentation of food to rodents 
maintained on a restricted feeding schedule (Waddington Lamont et al, 2007), stressors 
(Takahashi et al, 2001), and drugs of abuse (Masubuchi et al, 2000; Uz et al, 2005).  
The precise mechanisms by which each of these signals modifies the timing of the 
circadian clock are unknown; however, increasing evidence demonstrates that 
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dopamine (DA) signaling can modulate the expression of clock genes and proteins in 
brain regions associated with motivated behaviors, such as the striatum.  In particular, 
we and others have identified an important role of DA activity at D2 receptors in the 
regulation of clock gene expression in the striatum (Hood et al, 2010; Imbesi et al, 2009; 
Sahar et al).   
Many abused drugs, including opiates, increase extracellular concentrations of 
DA within terminal regions of the mesolimbic system, including dorsal and ventral 
striatum (Di Chiara and Imperato, 1988), prefrontal cortex (Moghaddam and Bunney, 
1989), BNST (Carboni et al, 2000), and amygdala (Harmer et al, 1997), whereas early 
withdrawal from repeated drug use is associated with a reduction in the activity of 
mesolimbic dopamine neurons and in extracellular dopamine levels (Acquas et al, 1991; 
Diana et al, 1999; Pothos et al, 1991; Rossetti et al, 1992; Tran-Nguyen et al, 1998).  
Interestingly, recent findings suggest that opiate exposure and withdrawal profoundly 
affect transcription rhythms of the clock genes, Period1 and Period2 (Per2) for at least 
one month in recently abstinent heroin users (Li et al, 2009a) and in rats undergoing 
spontaneous withdrawal from morphine (Li et al, 2009a; Li et al, 2010).  Thus, the 
circadian disturbances that arise during withdrawal from chronic use of opiates could be 
attributable to changes in the expression of clock genes and their proteins as a result of 
aberrant dopamine signaling patterns.   
We examined this issue in the present study by monitoring in rats the effect of a 
daily morphine injection and its subsequent withdrawal on 24-h patterns of wheel-
running activity and expression of the clock protein, PERIOD2 (PER2), in the SCN and 
a number of regions in the limbic forebrain.  These regions – namely, dorsal striatum, 
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oval nucleus of the bed nucleus of the stria terminalis (BNSTov), central nucleus of the 
amygdala (CEA), basolateral amygdala (BLA), and dentate gyrus of the hippocampus 
(DG) – are associated with the regulation of motivational states.  Furthermore, rhythms 
of clock gene expression in these regions are responsive to motivationally salient 
stimuli, such as restricted feeding (Waddington Lamont et al, 2007). We also examined 
whether treatments previously demonstrated to alleviate some symptoms of opiate 
withdrawal through modulation of midbrain DA activity would mitigate the effects of 
morphine withdrawal on wheel running and on PER2 patterns in the limbic forebrain.  To 
this end, we administered the dopamine D2/3 agonist, quinpirole (Harris and Aston-
Jones, 1994), or the alpha 2 adrenergic agonist, clonidine, which at low doses increases 
DA tone by inhibiting the overactivity of noradrenergic neurons in opiate withdrawal 
(Delfs et al, 2000; Dumont and Williams, 2004; Taylor et al, 1988), to rats for two days 
following the last morphine injection.  
 
MATERIALS AND METHODS 
Subjects 
48 male Wistar rats (Charles River, St. Constant, QC) weighing 250-275 g at the 
start of the experiment were housed singly in shoebox cages with running wheels and 
kept in individual lightproof and sound-attenuated cabinets. Within each cabinet, an 
overhead fluorescent tube provided light on a 12:12 light-dark (LD) schedule (light 
intensity within the cage was approximately 300 lux).  Wheel-running activity was 
monitored continuously by computer (VitalView, Minimitter, Sunview, OR, USA). 
Throughout the experiment, rats had ad libitum access to laboratory chow (Purina 
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Foods) and tap water.  All experimental procedures followed the guidelines of the 




Morphine hydrochloride (Sigma, Oakville, Ont.) was dissolved in saline.  
Quinpirole hydrochloride and clonidine hydrochloride (Sigma) were dissolved in distilled 
water.   
 
Immunohistochemistry 
At the end of the experiment, rats were given an overdose of sodium 
pentobarbital (Somnotol, 100 mg/kg) at their assigned zeitgeber time (ZT) (ZT1, 1 h 
after lights on, or ZT13, 1 h after lights off) and perfused intracardially with 300 ml of 
cold 0.09% saline, followed by 300 ml of cold 4 % paraformaldehyde in 0.1 M 
phosphate buffer.  Brains were extracted and kept in 4 % paraformaldehyde solution 
overnight at 4 ° C, then sectioned at 50 µm using a vibratome.  Sections were stored in 
Watson’s cryoprotectant (Watson et al, 1986) at –20 ° C until immunohistochemistry 
was performed.  Immunohistochemical staining for PER2 protein was carried out 
according to a protocol described previously (Hood et al, 2010) using an affinity-purified 
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Stained brain sections were examined under a light microscope using a 20x 
objective and 400 x 400 µm images of unilateral SCN, dorsal striatum, BNSTov, CEA, 
BLA, and DG were captured from each hemisphere using a Sony XC-77 video camera, 
a Scion LG-3 frame grabber, and Image SXM software (v1.8, S. D. Barrett, 
http://www.ImageSXM.org.uk).  The number of cells with nuclei immunoreactive (IR) for 
PER2 was then counted in each image captured. For each brain region of interest, the 
mean number of PER2-IR nuclei was calculated for each group by finding for each rat 
the mean cell count from six images having the highest number of labeled nuclei. 
Assay for plasma corticosterone 
To measure the effect of the daily morphine injection and its subsequent 
withdrawal on plasma levels of corticosterone, tail blood samples were collected from 
each rat approximately 10 min before it was killed.  Blood was centrifuged at 10000 rpm 
for 10 min at 4 ° C and the extracted plasma was stored at –80 ° C.  Corticosterone 
level in each plasma sample was measured using enzyme-linked immunosorbent assay 
(ELISA; Assay Designs, Ann Arbour, Michigan) according to manufacturer’s 
instructions. 
Procedure 
All rats were allowed to entrain to the LD cycle for 14 days before injections 
began.  Wheel running during the 12-h light and dark phases of the entrainment period 
was used to assign rats to either the saline or morphine injection condition to match the 
activity level of the groups before the course of daily injections began.  One group then 
received a daily intraperitoneal (i.p.) injection of morphine, between ZT3-4 (3-4 hours 
after lights turned on), whereas the other group received a daily saline injection.  The 
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dose of morphine began at 5 mg/kg and increased to 40 mg/kg in the following 
sequence over days: 5, 5, 10, 10, 20, 30, 40.  The 40 mg/kg dose was maintained for an 
additional 5 days for a total of 12 days of injections.   
Within the morphine and saline groups, rats were randomly assigned to one of 
four conditions in a 2 (withdrawal day 1 (WD-1) or withdrawal day 2 (WD-2)) by 2 (ZT1 
or ZT13) design (n = 3 per group). Rats assigned to the WD-1 condition were killed 
within 24 h of the final morphine or saline injection, at either ZT13 (10 h after the last 
injection) or ZT1 (22 h after the last injection). Rats assigned to the WD-2 condition 
received a saline injection at ZT13 in the evening after the last morphine or saline 
injection (as a control for the injections of quinpirole and clonidine given during 
withdrawal, see below).  The following day, they received no morphine or saline 
injection between ZT3-4, but as on the previous day, they received a saline injection in 
the evening at ZT13.  They were then killed the following day either at ZT1 (46 h after 
the last morphine or saline injection at ZT3-4) or at ZT13 (58 h after the last injection at 
ZT3-4).   
We chose to kill the rats at either ZT1 or ZT13 because these times represent the 
points at which the 24-h rhythms of PER2 in each forebrain region studied reach their 
peak and trough.  Examining PER2 expression at these two times provided a ‘snapshot’ 
of the effects of each manipulation on the normal maximum and minimum levels of 
PER2-IR in each brain region of interest. 
Effect of quinpirole following morphine withdrawal.   
To examine the effects of quinpirole on wheel running and PER2 expression 
following withdrawal of the daily morphine injection, rats received a daily injection of 
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saline or morphine at ZT3-4 for 12 days, as described above.  In the evening of the last 
morphine or saline injection day, rats received an injection of quinpirole (1 mg/kg, i.p.) at 
ZT13.  The next day, no injection of morphine or saline was given between ZT3-4, but 
as on the previous day, an injection of quinpirole was given at ZT13.  Rats were then 
killed the following day at either ZT1 (46 h after the last morphine or saline injection) or 
ZT13 (58 h after the last morphine or saline injection) (n = 3 per group).   
Effect of clonidine following morphine withdrawal. 
 To examine the effects of clonidine on wheel running and PER2 expression 
following withdrawal of the daily morphine injection, rats received a daily injection of 
morphine or saline at ZT3-4 for 12 days, as described above. In the evening of the last 
morphine or saline injection day, two injections of clonidine (0.1 mg/kg per injection, i.p.) 
were given – the first at ZT11 and the second at ZT13.  The next day, no injection of 
morphine or saline was given between ZT3-4, but as on the previous day, two injections 
of clonidine were given at ZT11 and ZT13.  Rats were then killed the following day at 
either ZT1 (46 h after the last morphine or saline injection) or ZT13 (58 h after the last 
morphine or saline injection) (n = 3 per group). 
Statistical analyses 
Independent samples t-tests were used to compare wheel running in the 
morphine and saline groups during the 12-h light and 12-h dark periods during the 12-
day injection period, the 3 h before the daily morphine or saline injection was given 
(ZT0-3), and the hour after the daily injection (ZT4-5). To test the effect of withdrawing 
the daily morphine or saline injection on wheel running, on corticosterone levels, and on 
PER2-IR nuclei in each brain region of interest, two-way analyses of variance (ANOVA) 
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were carried out using daily injection condition (saline or morphine) and withdrawal time 
(WD-1 or WD-2) as factors.  Additional two-way ANOVA were used to test the effect of 
either quinpirole or clonidine treatment following morphine withdrawal on each 
dependent variable of interest using daily injection condition (saline or morphine) and 
withdrawal treatment ((quinpirole or clonidine) or saline) as factors.  Significant 
interactions were further analyzed using independent samples t-tests. Alpha level for all 
tests was set at 0.05. 
      
RESULTS 
Wheel running during daily morphine injections 
Figure 1a shows average (+/- SEM) wheel-running activity in the 12-h light and 
dark phases from the 12-day period of daily morphine or saline injections.  It can be 
seen that a daily injection of morphine significantly suppressed activity in the wheel 
during the 12-h dark phase, when rats are normally most active (t (46) = 3.24, p < 0.01), 
whereas morphine- and saline-injected groups did not differ in wheel-running activity in 
the 12-h light phase (t (46) = 1.04, n.s.).  To examine whether this suppression of 
nighttime activity by morphine was dependent on the dose of morphine, we examined 
wheel running in the 12-h dark phase during the first two days of morphine injection (5 
mg/kg) and during the first two days of injections of the highest morphine dose (40 
mg/kg) (data not shown).  Although nighttime wheel running was decreased within the 
first two days of morphine injections, activity in the morphine group at the 5 mg/kg dose 
was not significantly different from the saline-injected group.  At the 40 mg/kg dose of 
morphine, however, nighttime wheel running was significantly suppressed (t (46) = 3.84, 
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p < 0.01).  These results indicate that morphine dose-dependently reduces wheel-
running activity in the dark phase.  
Previous reports indicate that rats given a daily injection of a drug of abuse, such 
as nicotine or amphetamine, develop increased activity in a running wheel in the hours 
preceding the daily injection (Kosobud et al, 2007; Nikaido et al, 2001; Shibata et al, 
1994).  To determine whether rats receiving a daily injection of morphine developed a 
similar increase, we examined activity in the wheel during the three hours preceding the 
daily injection (between ZT0-3) from the last 6 days of the injection period (when the 40 
mg/kg morphine dose was injected). Morphine-injected rats ran somewhat less than 
saline-injected rats during the 3 h before the daily injection, although this difference was 
not significant (t (46) = 1.74, n.s.) (data not shown).  To establish whether morphine 
differentially affected wheel-running activity after the injection, we examined wheel 
running in the hour following the daily injection (ZT4-5).  Morphine- and saline-injected 
rats did not differ in wheel running during this hour (data not shown).  Taken together, 
these findings indicate that the effects of a daily morphine injection on wheel running 
were evident only in the dark phase, which began 9 h after the time of injection.   
 
Wheel running after withdrawal of morphine and treatment with quinpirole or clonidine  
Figure 1b shows wheel running during the 12-h light and dark phases on the day 
when no morphine or saline injection was given at ZT3-4.  It can be seen that rats 
previously injected with morphine (morphine WD-2 + sal) ran significantly less during 
the dark phase than did rats previously injected with saline (saline WD-2 + sal) (t (10) = 
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3.62, p < 0.01).  Groups did not differ in wheel running during the light phase on this 
day.   
Figure 1b also shows the effect of quinpirole and clonidine treatment, injected in 
the evenings following the last daytime morphine injection, on wheel-running activity. It 
can be seen that neither quinpirole treatment following the last morphine exposure 
(morphine WD-2 + Q) nor clonidine (morphine WD-2 + CL) restored nighttime activity in 
the running wheel.  
The effects of quinpirole and clonidine injections alone on wheel running were 
examined in rats previously given daytime injections of saline.  These data are shown in 
Figure 1c. Interestingly, quinpirole (saline WD-2 + Q) significantly suppressed nighttime 
wheel running in comparison to saline control (saline WD-2 + saline) (t (10) = 3.95, p < 
0.01).  Quinpirole injections did not affect wheel running during the light phase.  
Clonidine treatment had no effect on wheel running in the light or dark phases in rats 
previously injected with saline (saline WD-2 + CL).  Taken together, these results 
indicate that although neither quinpirole nor clonidine significantly affected the reduction 
in nighttime wheel running observed following withdrawal of the daily morphine injection, 
quinpirole itself decreased nighttime activity in rats previously injected with saline. 
 
Plasma corticosterone levels 
 In rats, circulating levels of corticosterone fluctuate in a circadian rhythm that 
peaks just before the transition from the inactive (or light) phase to the active (or dark) 
phase (Oster et al, 2006).  Previous reports indicate that basal corticosterone levels in 
rodents increase following the cessation of long-term opiate treatment (Pechnick, 1993).  
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In the present experiment, we measured corticosterone at ZT1 (when corticosterone is 
normally low) and at ZT13 (when corticosterone is normally high) in rats given daily 
injections of saline or morphine and killed either within 24 h of the last injection or two 
days later.  In rats killed within 24 h of the final morphine injection, the daily fluctuation 
in corticosterone levels was no different from saline-injected rats (data not shown).  In 
rats killed two days after withdrawal of morphine (morphine WD-2), corticosterone levels 
at ZT1 were significantly elevated in comparison to saline-injected rats (t (4) = -6.95, p < 
0.05), such that the normal fluctuation in corticosterone between ZT1 and ZT13 in this 
group was lost (t (4) = -0.29, n.s.).  These results are consistent with previous reports 
that corticosterone levels increase following withdrawal of repeated opiate exposure and 
that the normal rhythm of secretion of this hormone is disrupted in withdrawal (Li et al, 
2010; Pechnick, 1993). 
Corticosterone levels were also measured in groups given quinpirole. Quinpirole 
did not affect the elevation of corticosterone at ZT1 seen in rats given saline following 
the withdrawal of morphine.  At ZT13, however, quinpirole significantly decreased the 
normal rise in corticosterone levels in both morphine- and saline-injected groups (main 
effect of quinpirole, F (1, 8) = 8.37, p < 0.05).   
Injections of clonidine decreased the elevation in corticosterone levels seen at 
ZT1 following the withdrawal of morphine, although this effect was not significant.  At 
ZT13, clonidine significantly decreased corticosterone in both morphine- and saline-
injected groups (main effect of clonidine, F (1, 8) = 5.87, p < 0.05).  Thus, these results 
indicate that the elevation of daytime corticosterone levels following withdrawal of 
morphine can be partially decreased by clonidine injections.  Both quinpirole and 
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clonidine injections themselves, given in the evening, however, significantly blunt the 
normal nighttime rise in corticosterone.   
 
PER2 expression  
 SCN 
In the SCN, PER2-IR nuclei reach their lowest levels at the beginning of the light 
phase (ZT1) and are most abundant just after the transition from the light to dark phase 
(ZT13).  Figure 2a shows the number of PER2-IR nuclei expressed in the SCN at each 
of these timepoints in rats killed within 24 h of the final injection of morphine or saline at 
ZT3-4.  Figure 2b shows PER2-IR nuclei in rats killed two days after the final injection.  
In both figures, it can be seen that daily injections of morphine and their subsequent 
withdrawal had no effect on the normal pattern of PER2 expression in the SCN, 
indicating that morphine withdrawal does not influence the activity of the master clock.   
Figure 2b also shows the effects of administering quinpirole (morphine WD-2 + 
Q) or clonidine (morphine WD-2 + CL) in the evenings following the last morphine 
injection on PER2 in the SCN.  Neither treatment significantly affected the normal PER2 
pattern in morphine-injected rats.  Furthermore, as shown in Figure 2c, in saline-injected 
rats neither quinpirole (saline WD-2 + Q) nor clonidine treatment (saline WD-2 + CL) 
had any effect on the normal pattern of PER2 expression.  
Dorsal striatum 
PER2 expression in the dorsal striatum is lowest at the beginning of the dark 
phase and greatest at the beginning of the light; thus, its daily PER2 pattern is opposite 
to that in the SCN.  As shown in Figure 3a, in rats killed within 24 h of the last daily 
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injection of morphine, PER2 was significantly increased at ZT13 (10 h after the last 
morphine injection) (t (4) = -3.66, p < 0.05), whereas PER2 expression at ZT1 (22 h 
after the last injection) was suppressed (t (4) = 5.63, p < 0.01).  
Figure 3b shows the pattern of PER2 expression in rats killed two days after the 
last daily injection at ZT3-4.  In rats previously injected with morphine (morphine WD-2 + 
sal), it can be seen that the normal peak of PER2 at ZT1 (46 h after the last injection) 
was blunted compared to rats previously injected with saline (saline WD-2 + sal) (t (4) = 
4.49, p < 0.05).  Figure 3b also illustrates the effect of quinpirole or clonidine treatment 
following withdrawal of morphine injections on PER2 expression in the striatum.  
Evening injections of quinpirole (morphine WD-2 + Q) did not restore PER2 expression 
at ZT1, but increased PER2 at ZT13 (t (4) = -2.99, p < 0.04) in comparison to saline 
treatment. Clonidine treatment (morphine WD-2 + CL) also did not restore PER2 
expression at ZT1 in rats previously injected with morphine, but significantly increased 
PER2 at ZT13 (t (4) = -8.01, p < 0.01).   
Figure 3c shows the effect of quinpirole or clonidine alone on PER2 expression in 
rats previously given daily injections of saline at ZT3-4.  Quinpirole itself (saline WD-2 + 
Q) significantly suppressed the normal peak of PER2 at ZT1 (t (4) = 3.20, p < 0.05).  In 
contrast, clonidine (saline WD-2 + CL) did not affect the normal pattern of PER2 in the 
striatum.  Taken together, these results indicate that withdrawal of daily morphine 
injections blunts the normal peak of PER2 expression in the dorsal striatum, and that a 
daily increase in PER2 expression can be reinstated partially by quinpirole or fully by 
clonidine.  Quinpirole itself, however, blunts the normal peak of PER2 expression in the 
striatum.   
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 In the BNSTov, the daily fluctuation of PER2 expression rises toward the 
beginning of the dark phase (ZT13) and falls during the light (ZT1), and thus coincides 
with the PER2 pattern in the SCN.  As shown in Figure 4a, in rats killed within 24 h of 
the last morphine injection, PER2 expression at ZT13 (10 h after the last injection) was 
significantly decreased (t (4) = 3.11, p < 0.05).   
Figure 4b shows the pattern of PER2 expression in rats killed two days after the 
last daily injection at ZT3-4.  In rats killed two days after the final morphine injection 
(morphine WD-2 + sal), PER2 at ZT13 (58 h after the last injection) was significantly 
decreased (t (3) = 4.79, p < 0.05).  Figure 4b also shows the effect on PER2 of 
quinpirole and clonidine treatment following the last morphine injection.  Quinpirole 
(morphine WD-2 + Q) increased PER2 expression at ZT13, although this effect was not 
significant.  Clonidine (morphine WD-2 + CL) significantly increased PER2 at ZT1 (t (4) 
= -5.65, p < 0.05), but did not affect the blunted expression of PER2 at ZT13.  
 Figure 4c shows the effects of quinpirole and clonidine treatments alone on 
PER2 expression in rats previously injected with saline at ZT3-4.  Quinpirole itself 
(saline WD-2 + Q) did not affect the normal PER2 pattern. Clonidine (saline WD-2 + CL) 
significantly increased PER2 expression at ZT1 (t (3) = -5.79, p < 0.01) and suppressed 
the normal peak of PER2 at ZT13 (t (3) = 4.25, p < 0.05).  Thus, these results indicate 
that withdrawal of morphine blunts the normal PER2 peak in the BNSTov, and that 
evening injections of quinpirole can increase PER2 expression at ZT13.  Clonidine 
S. Amir 
Morphine withdrawal disrupts PER2. 
17
treatment, either alone or in combination with morphine withdrawal, establishes a new 
pattern of PER2 expression in the BNSTov. 
 CEA 
 As shown in Figure 5a, the normal pattern of PER2 expression in the CEA peaks 
at ZT13 and falls near ZT1, and is thus in phase with the BNSTov and SCN.  In rats 
killed within 24 h of the last morphine injection (Figure 5a), PER2 was significantly 
increased at ZT1 (22 h after the last injection) (t (4) = -4.54, p < 0.01), the time at which 
PER2 is normally lowest in this region, and was reduced at ZT13 (10 h after the 
injection).   
Figure 5b shows the pattern of PER2 expression in rats killed two days after the 
last daily injection at ZT3-4.  It can be seen that in rats previously injected with morphine 
(morphine WD-2 + sal), PER2 expression at ZT1 (46 h after the last injection) was 
unaffected, but the normal peak of PER2 at ZT13 (58 h after the last injection) was 
blunted  (t (4) = 2.67, p = 0.05).  Figure 5b also shows the effects of quinpirole or 
clonidine treatment following morphine withdrawal.  Quinpirole (morphine WD-2 + Q) 
increased PER2 at ZT13, although this increase was not statistically significant.  
Clonidine treatment (morphine WD-2 + CL) following withdrawal of morphine non-
significantly increased PER2 expression at ZT1, and had no effect on the blunted 
expression of PER2 at ZT13.  
 Figure 5c shows the effect of quinpirole and clonidine alone in saline-injected 
rats.  Quinpirole itself (saline WD-2 + Q) did not affect the normal PER2 pattern in this 
region, whereas clonidine (saline WD-2 + CL) increased PER2 expression at ZT1 (t (4) 
= -10.56, p < 0.01) and decreased PER2 at ZT13 (t (4) = 3.55, p < 0.05).  Together, 
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these results show that the normal daily PER2 pattern in the CEA is disrupted by daily 
morphine injection and withdrawal.  Quinpirole treatment following morphine withdrawal 
increased PER2 at ZT13, the time at which its expression normally peaks, whereas 
clonidine treatment did not significantly affect the pattern of PER2 following morphine 
withdrawal.  Clonidine alone, however, disrupted the normal pattern of PER2 expression 
in saline-injected rats.   
 
 BLA 
In the BLA, PER2 expression peaks near ZT1 and falls to a trough level near 
ZT13, thereby resembling the pattern observed in the dorsal striatum.  As shown in 
Figure 6a, in rats killed within 24 h of the last morphine injection, PER2 expression at 
ZT13 (10 h after the last injection) was significantly increased (t (4) = -5.07, p < 0.01) 
whereas PER2 at ZT1 (22 h after the last injection) was significantly blunted (t (4) = 
4.97, p < 0.01).   
Figure 6b shows the pattern of PER2 expression in rats killed two days after the 
last daily injection at ZT3-4.  It can be seen that in rats killed following the last morphine 
injection (morphine WD-2 + sal), PER2 at ZT1 (46 h after the last injection) was blunted 
(t (4) = 3.03, p < 0.05).  Quinpirole treatment following the last morphine injection 
(morphine WD-2 +Q) had no effect on this decrease in PER2 expression at ZT1. 
Clonidine (morphine WD-2 + CL), however, restored and induced a new pattern of 
PER2 expression in rats previously injected with morphine, such that PER2 was 
significantly increased at ZT13 (t (4) = -5.16, p < 0.01).   
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The effect of quinpirole and clonidine treatments in saline-injected rats is shown 
in Figure 6c.  Quinpirole itself (saline WD-2 + Q) significantly suppressed the normal 
peak of PER2 expression at ZT1 (t (4) = 7.55, p < 0.01).  Clonidine (saline WD-2 + CL) 
did not affect PER2 expression at ZT1, but increased PER2 expression at ZT13 (t (4) = 
-4.60, p < 0.05).  Thus, these results indicate that daily morphine injection and 
withdrawal blunts the normal rise in PER2 in the BLA.  Quinpirole treatment following 
withdrawal does not restore a normal pattern of PER2 expression, whereas clonidine 
establishes a new pattern of PER2 expression in withdrawal.  Each of these two 
treatments also significantly disrupts the normal pattern of PER2 in saline-injected rats.     
DG 
The daily pattern of PER2 expression in the DG peaks near ZT1 and falls to a 
trough level near ZT13, and is thus in phase with the patterns in the BLA and dorsal 
striatum.  As shown in Figure 7a, in rats killed within 24 h of the last morphine injection 
PER2 expression at ZT1 (22 h after the last injection) was significantly blunted (t (4) = 
3.27, p < 0.01).   
Figure 7b shows the pattern of PER2 expression in rats killed 2 days after the 
last daily injection at ZT3-4.  It can be seen that in rats killed following the withdrawal of 
morphine (morphine WD-2 + sal), PER2 expression at ZT1 (46 h after the last injection) 
was blunted (t (4) = 7.41, p < 0.01).  The effect of quinpirole or clonidine following 
morphine withdrawal is also shown in Figure 7b.  In rats given quinpirole in the evening 
following the last morphine injection (morphine WD-2 + Q), PER2 expression was 
increased at both ZT1 (t (4) = -2.78, p = 0.05) and ZT13 (t (4) = -3.58, p < 0.05).  
Clonidine treatment (morphine WD-2 + CL) following morphine withdrawal induced a 
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new pattern of PER2 expression, whereby PER2 was increased at ZT13 (t (4) = -13.39, 
p < 0.01). 
Figure 7c shows the effects of quinpirole and clonidine alone in saline-injected 
rats.  Quinpirole itself (saline WD-2 + Q) significantly blunted the normal peak of PER2 
expression at ZT1 (t (4) = 7.67, p < 0.01).  Clonidine (saline WD-2 + CL) appeared to 




The present findings show that in rats, housed in 12:12 LD, scheduled daily 
injections of morphine given early in the light phase disrupt the normal circadian pattern 
of wheel-running activity, such that running in the dark phase (beginning 9 h after the 
daily injections) is completely suppressed at the higher doses of morphine.  Daily 
morphine injections and their subsequent withdrawal also markedly disrupt the daily 
pattern of PER2 expression in several regions of the limbic forebrain including dorsal 
striatum, BNSTov, CEA, BLA, and DG without affecting the PER2 rhythm in the SCN, 
itself.  Injections of the D2/3 DA agonist, quinpirole, following withdrawal of morphine 
restored normal patterns of PER2 in the BNSTov and CEA, whereas injections of the 
alpha 2 adrenergic agonist, clonidine, restored PER2 expression in the dorsal striatum, 
BLA, and DG.   
 
Nighttime wheel-running activity  
 
To our knowledge, the pronounced effect of daily morphine injections on wheel-
running activity during the dark phase has not been reported previously.   Other studies 
using different methods of drug delivery and different light schedules have shown that 
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opiate receptor agonists can alter circadian activity rhythms, for example by phase 
shifting the rhythm of wheel running in mice housed in constant dim light (Marchant and 
Mistlberger, 1995; Vansteensel et al, 2005).  Interestingly, we have given daily 
injections of morphine (5 – 40 mg/kg) in the middle of the inactive phase to rats housed 
in constant darkness (DD) and have not observed any shift in the phase of the wheel-
running rhythm (unpublished observations).  Consistent with the present findings under 
12:12 LD conditions, however, in these rats housed in DD the amplitude of wheel 
running during the subjective night was reduced. 
One possible explanation for the reduction in nighttime wheel-running activity 
could be the development of withdrawal symptoms over the 24 h following the morning 
morphine injection.  Indeed, nighttime wheel running was significantly decreased only 
when the higher doses of morphine were given and remained suppressed the day after 
the last morphine injection was given. Withdrawal symptoms have been reported to 
emerge relatively rapidly (within 14 h after a final injection) in rats given twice-daily 
morphine injections over one week (Li et al, 2009a).  Furthermore, spontaneous 
withdrawal from chronic morphine treatment, delivered via subcutaneous pellet or twice-
daily injections, has been found to diminish nighttime locomotor activity in rats (Georges 
et al, 1999; Stinus et al, 1998).  Given that our injections were made eight to nine hours 
before lights were turned off, the emergence of some withdrawal symptoms over the 
course of the dark period could have interfered with the ability or motivation to run.  
An alternative hypothesis is that the effect of morphine on nighttime wheel 
running is associated with its effects on the daily pattern of PER2 expression in the 
dorsal striatum. As shown in Figures 3a and 3b, the normal peak of PER2 expression in 
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the dorsal striatum was suppressed both in rats killed within 24 h after the last morphine 
injection and 2 days after the last injection.  Similarly, injections of quinpirole in saline-
treated rats were found to both suppress nighttime activity in the wheel (Figure 1c) and 
blunt the normal peak of PER2 at ZT1 in the striatum (Figure 3c).  Given the prominent 
role of the dorsal striatum in the regulation of movement, it is possible that rhythmic 
clock gene expression in this region could be functionally related to the circadian 
modulation of locomotor activity.  Consistent with this, we have found that by one week 
after the last morphine injection, both a high level of wheel-running activity in the dark 
phase and the normal daily pattern of PER2 in the dorsal striatum are re-established 
(unpublished observations).  Additional evidence from the literature lends support to this 
argument.  For example, Masubuchi and colleagues (2000) have shown that in rats 
housed on a 12:12 LD cycle and given ad libitum access to methamphetamine (in the 
drinking water), rhythms of wheel-running activity and clock gene expression in the 
striatum gradually desynchronize from the LD schedule and from clock gene expression 
in the SCN, but remain in phase with each other.   
 
Effects of morphine on daytime wheel-running activity 
As noted above, several reports in the literature suggest that rats develop 
anticipatory locomotor activity to a predictable daily injection of a drug of abuse, such as 
methamphetamine and nicotine (Iijima et al, 2002; Kosobud et al, 2007; Shibata et al, 
1994), but not to other drugs that lack abuse potential, such as haloperidol (Kosobud et 
al, 2007).  This phenomenon has been compared to the food anticipatory activity 
exhibited by rats maintained on a daytime restricted feeding schedule.  In the present 
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study, however, rats receiving a daily injection of morphine showed no evidence of 
increased wheel running during the 3 h preceding the daily injection.  Thus, these 
findings do not support the claim that a daily injection of an abused drug entrains a bout 
of increased wheel-running activity.  
It is possible, however, that morphine-treated rats demonstrated signs of 
anticipation of the daily morphine injection in rhythmic functions other than wheel 
running that were not monitored in the present study.  For example, Eikelboom and 
Stewart (1979) reported that in rats given injections of morphine at the same time of day 
over many days, body temperature decreased in a 1-h period in advance of the 
injection.  This hypothermia was found to occur whether or not rats were tested in the 
same environment that predicted drug injections, suggesting that the decrease in 
temperature was mediated via a circadian mechanism.  
 
Effect of morphine withdrawal on PER2 expression 
Our findings reveal that morphine withdrawal profoundly affects the daily 
fluctuation of PER2 expression in several limbic forebrain regions without disrupting the 
rhythm of PER2 expression in the SCN.  This latter finding in the SCN is consistent with 
previous findings showing that rhythmic activity in the adult rat SCN is unresponsive to 
exposure to drugs of abuse (Masubuchi et al, 2000), and to manipulations of 
catecholamine levels in the forebrain (Hood et al, 2010).  
In contrast, however, in each of the forebrain regions examined, the normal daily 
peak of PER2 expression was suppressed in rats killed 2 days after the withdrawal of 
morphine.  Although the specific mechanisms underlying this suppression remain 
unclear, changes in the normal daily rhythms of extracellular catecholamine levels, and 
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specifically DA, as a result of the daily morphine injections could play a role in this 
effect.  We have demonstrated previously that the rhythm of extracellular DA in the 
striatum, which rises during the dark or active phase (Castaneda et al, 2004; Paulson 
and Robinson, 1994), regulates the daily PER2 pattern in this region (Hood et al, 2010).  
Loss of normal DA tone blunts the normal peak of PER2 in the striatum, whereas timed 
stimulation of D2 receptors using injections of quinpirole entrains a new pattern of PER2 
expression. Given that acute injections of morphine, and several other abused drugs, 
stimulate release of DA in terminal regions of the mesolimbic system, whereas 
withdrawal of morphine is associated with a reduction in basal DA levels in several 
regions including the striatum (Pothos et al, 1991; Rossetti et al, 1992) and amygdala 
(Tran-Nguyen et al, 1998), it is likely that the present schedule of morphine injections in 
the light phase and their subsequent termination disrupted the normal rhythm of 
extracellular DA.   
In support of the proposal that changes in DA signaling mediate the observed 
changes in PER2 expression, we found that injections of two different drugs known to 
modulate the activity of midbrain DA systems could restore a daily fluctuation in PER2 
following morphine withdrawal.  Injections of the D2/3 DA agonist, quinpirole, have been 
found to alleviate several somatic symptoms of opiate withdrawal in rats such as wet 
dog shakes and teeth chattering (Harris et al, 1994).  Here, we found that quinpirole 
restored PER2 expression in the BNSTov and CEA, and more modestly increased 
PER2 around the time of its injection (ZT13) in the striatum and DG. Interestingly, 
quinpirole blunted the normal peak of PER2 expression at ZT1 in the dorsal striatum, 
BLA, and DG in rats previously given daily injections of saline.  Although not directly 
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tested here, this effect in the dorsal striatum is likely attributable to the inhibitory effects 
of quinpirole at low doses on the activity of DA neurons via activation of D2 
autoreceptors (Jeziorski and White, 1989; Lacey et al, 1987).  In the present study, 
quinpirole was injected at the beginning of the dark phase, when extracellular DA levels 
are normally rising; as such, one likely effect of quinpirole given at this time in morphine-
naïve rats is a reduction in evening DA levels and, in turn, a blunting of the normal peak 
of PER2 in these regions. 
Injections of the alpha 2 adrenergic agonist, clonidine, have also been 
demonstrated to modulate the activity of midbrain DA neurons in opiate withdrawal 
(Pothos et al, 1991).  In rats, clonidine injections increase DA levels in terminal regions 
of the mesolimbic system during opiate withdrawal by inhibiting a noradrenaline-
mediated suppression of midbrain DA neuron activity (Dumont et al, 2004).  Here, we 
found that evening injections of clonidine restored and entrained a new pattern of PER2 
expression in the striatum, BNSTov, BLA, and DG following morphine withdrawal.  
These results suggest that administration of drugs that stimulate DA signaling at the 
beginning of the dark phase, when dopamine levels would normally increase in terminal 
regions of the mesolimbic dopamine system, can reverse the loss of PER2 expression 
in morphine withdrawal.  Given that quinpirole and clonidine had differential effects on 
PER2 expression according to the forebrain region examined, however, additional 
mechanisms unique to each treatment and perhaps to each region are likely contribute 
to the pattern of results obtained here.  
The effects of morphine and withdrawal on catecholamine signaling are not 
limited to DA, however, and thus the changes in PER2 expression observed in 
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morphine-treated rats could also be mediated by changes in other neurotransmitters, 
such as noradrenaline.  Noradrenaline has been shown previously to modulate clock 
gene expression in the brain and periphery (Simonneaux et al, 2004; Terazono et al, 
2003; Warnecke et al, 2005).  In the present study we saw that clonidine injections 
given to saline-treated rats had effects on patterns of PER2 in some regions of the brain 
that were different from the effects of the direct DA agonist.   
Finally, it is interesting to speculate on the relation between the disturbances in 
rhythms of clock protein expression in the limbic forebrain and the physiological and 
motivational symptoms associated with opiate withdrawal.  For example, loss of normal 
rhythmic activity in the BNSTov, CEA, and DG might contribute to the disrupted 
corticosterone rhythm following morphine withdrawal, as these regions play important 
roles in the regulation of HPA axis activity (Forray and Gysling, 2004; Herman and 
Cullinan, 1997; Xu et al, 1999).  Disturbances in motivational states, including dysphoria 
and anxiety, are also frequently reported during withdrawal from chronic opiate use 
(Wikler, 1973).  Given that each of the forebrain regions examined in the present study 
is implicated in the regulation of motivated behavior, the disruption of normal clock 
activity (and presumably normal cellular functioning) in these tissues as a result of 
morphine withdrawal might contribute to these aversive motivational states.  
 
CONCLUSION 
Taken together, our results show dramatic effects of daily morphine injections, 
given in the light phase, on circadian rhythms of wheel running and expression of PER2 
in the limbic forebrain.  Morphine-treated rats exhibit profound suppression of normal 
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nighttime wheel-running activity and major changes in daily patterns of PER2 
expression in the dorsal striatum, BNSTov, CEA, BLA, and DG, although no effects 
were seen on the pattern of PER2 expression in the SCN.  Administration of quinpirole 
or clonidine following the last morphine injection restored a daily fluctuation in PER2 
expression in these forebrain nuclei, although the effects of each drug varied as a 
function of region.  Together, these findings implicate disruptions in normal daily 
patterns of clock protein expression in the circadian features of opiate withdrawal.  
Furthermore, they suggest that treatments known to alleviate opiate withdrawal 
symptoms might do so in part by modulating clock protein expression patterns in the 
limbic forebrain.  
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Figure Captions 
Figure 1. (a) Wheel-running activity in the 12-h light (open bars) and 12-h dark (filled 
bars) phases by rats given a daily injection of either saline or morphine at ZT3-4.  Bars 
represent the average (± SEM) of wheel running in each phase over the 12 days of 
injections. (b) Mean wheel-running activity (± SEM) in the light and dark phases on the 
day after the final saline or morphine injection at ZT3-4.  At the beginning of the dark 
phase following the final daytime injection, rats received an injection of saline (saline 
WD-2 + sal; morphine WD-2 + sal), quinpirole (1 mg/kg) (morphine WD-2 + Q), or 
clonidine (0.1 mg/kg) (morphine WD-2 + CL). (c) Mean wheel running (± SEM) in the 
light and dark phases by rats previously injected with saline at ZT3-4.  At the beginning 
of the dark phase following the last daytime saline injection, rats received an injection of 
saline (saline WD-2 + sal), quinpirole (saline WD-2 + Q), or clonidine (saline WD-2 + 
CL).  * indicates a significant difference, p < 0.05.   
 
Figure 2.  Daily fluctuation of PER2-immunoreactive (IR) nuclei in the SCN.  (a) Mean 
PER2-IR nuclei (± SEM) in rats killed within 24 h after the final daily saline (saline WD-
1) or morphine (morphine WD-1) injection at ZT3-4.  Rats were killed either in the 
evening after the last injection at ZT13 (10 h after the injection, filled bars) or the 
following morning at ZT1 (22 h after the injection, open bars).  (b) Mean PER2-IR nuclei 
(± SEM) at ZT1 or ZT13 in rats killed 2 days after the last daily saline or morphine 
injection.  At the beginning of the dark phase following the final daytime injection, rats 
received an injection of saline (saline WD-2 + sal; morphine WD-2 + sal), quinpirole (1 
mg/kg) (morphine WD-2 + Q), or clonidine (0.1 mg/kg) (morphine WD-2 + CL).  (c) 
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Mean PER2-IR nuclei (± SEM) in rats previously injected with saline at ZT3-4.  At the 
beginning of the dark phase following the last daytime saline injection, rats received an 
injection of saline (saline WD-2 + sal), quinpirole (saline WD-2 + Q), or clonidine (saline 
WD-2 + CL). * indicates a significant difference, p < 0.05.   
 
Figure 3.  Daily fluctuation of PER2-immunoreactive (IR) nuclei in the dorsal striatum.  
(a) Mean PER2-IR nuclei (± SEM) in rats killed within 24 h after the final daily saline 
(saline WD-1) or morphine (morphine WD-1) injection at ZT3-4.  Rats were killed either 
in the evening after the last injection at ZT13 (10 h after the injection, filled bars) or the 
following morning at ZT1 (22 h after the injection, open bars).  (b) Mean PER2-IR nuclei 
(± SEM) at ZT1 or ZT13 in rats killed 2 days after the last daily saline or morphine 
injection.  At the beginning of the dark phase following the final daytime injection, rats 
received an injection of saline (saline WD-2 + sal; morphine WD-2 + sal), quinpirole (1 
mg/kg) (morphine WD-2 + Q), or clonidine (0.1 mg/kg) (morphine WD-2 + CL).  (c) 
Mean PER2-IR nuclei (± SEM) in rats previously injected with saline at ZT3-4.  At the 
beginning of the dark phase following the last daytime saline injection, rats received an 
injection of saline (saline WD-2 + sal), quinpirole (saline WD-2 + Q), or clonidine (saline 
WD-2 + CL). * indicates a significant difference, p < 0.05. 
 
 
Figure 4.  Daily fluctuation of PER2-immunoreactive (IR) nuclei in the BNSTov. (a) 
Mean PER2-IR nuclei (± SEM) in rats killed within 24 h after the final daily saline (saline 
WD-1) or morphine (morphine WD-1) injection at ZT3-4.  Rats were killed either in the 
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evening after the last injection at ZT13 (10 h after the injection, filled bars) or the 
following morning at ZT1 (22 h after the injection, open bars).  (b) Mean PER2-IR nuclei 
(± SEM) at ZT1 or ZT13 in rats killed 2 days after the last daily saline or morphine 
injection.  At the beginning of the dark phase following the final daytime injection, rats 
received an injection of saline (saline WD-2 + sal; morphine WD-2 + sal), quinpirole (1 
mg/kg) (morphine WD-2 + Q), or clonidine (0.1 mg/kg) (morphine WD-2 + CL).  (c) 
Mean PER2-IR nuclei (± SEM) in rats previously injected with saline at ZT3-4.  At the 
beginning of the dark phase following the last daytime saline injection, rats received an 
injection of saline (saline WD-2 + sal), quinpirole (saline WD-2 + Q), or clonidine (saline 
WD-2 + CL). * indicates a significant difference, p < 0.05.  
 
Figure 5.  Daily fluctuation of PER2-immunoreactive (IR) nuclei in the CEA.   
(a) Mean PER2-IR nuclei (± SEM) in rats killed within 24 h after the final daily saline 
(saline WD-1) or morphine (morphine WD-1) injection at ZT3-4.  Rats were killed either 
in the evening after the last injection at ZT13 (10 h after the injection, filled bars) or the 
following morning at ZT1 (22 h after the injection, open bars).  (b) Mean PER2-IR nuclei 
(± SEM) at ZT1 or ZT13 in rats killed 2 days after the last daily saline or morphine 
injection.  At the beginning of the dark phase following the final daytime injection, rats 
received an injection of saline (saline WD-2 + sal; morphine WD-2 + sal), quinpirole (1 
mg/kg) (morphine WD-2 + Q), or clonidine (0.1 mg/kg) (morphine WD-2 + CL).  (c) 
Mean PER2-IR nuclei (± SEM) in rats previously injected with saline at ZT3-4.  At the 
beginning of the dark phase following the last daytime saline injection, rats received an 
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injection of saline (saline WD-2 + sal), quinpirole (saline WD-2 + Q), or clonidine (saline 
WD-2 + CL). * indicates a significant difference, p < 0.05.   
 
Figure 6.  Daily fluctuation of PER2-immunoreactive (IR) nuclei in the BLA.  
(a) Mean PER2-IR nuclei (± SEM) in rats killed within 24 h after the final daily saline 
(saline WD-1) or morphine (morphine WD-1) injection at ZT3-4.  Rats were killed either 
in the evening after the last injection at ZT13 (10 h after the injection, filled bars) or the 
following morning at ZT1 (22 h after the injection, open bars).  (b) Mean PER2-IR nuclei 
(± SEM) at ZT1 or ZT13 in rats killed 2 days after the last daily saline or morphine 
injection.  At the beginning of the dark phase following the final daytime injection, rats 
received an injection of saline (saline WD-2 + sal; morphine WD-2 + sal), quinpirole (1 
mg/kg) (morphine WD-2 + Q), or clonidine (0.1 mg/kg) (morphine WD-2 + CL).  (c) 
Mean PER2-IR nuclei (± SEM) in rats previously injected with saline at ZT3-4.  At the 
beginning of the dark phase following the last daytime saline injection, rats received an 
injection of saline (saline WD-2 + sal), quinpirole (saline WD-2 + Q), or clonidine (saline 
WD-2 + CL). * indicates a significant difference, p < 0.05. 
 
Figure 7.  Daily fluctuation of PER2-immunoreactive (IR) nuclei in the DG.  
(a) Mean PER2-IR nuclei (± SEM) in rats killed within 24 h after the final daily saline 
(saline WD-1) or morphine (morphine WD-1) injection at ZT3-4.  Rats were killed either 
in the evening after the last injection at ZT13 (10 h after the injection, filled bars) or the 
following morning at ZT1 (22 h after the injection, open bars).  (b) Mean PER2-IR nuclei 
(± SEM) at ZT1 or ZT13 in rats killed 2 days after the last daily saline or morphine 
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injection.  At the beginning of the dark phase following the final daytime injection, rats 
received an injection of saline (saline WD-2 + sal; morphine WD-2 + sal), quinpirole (1 
mg/kg) (morphine WD-2 + Q), or clonidine (0.1 mg/kg) (morphine WD-2 + CL).  (c) 
Mean PER2-IR nuclei (± SEM) in rats previously injected with saline at ZT3-4.  At the 
beginning of the dark phase following the last daytime saline injection, rats received an 
injection of saline (saline WD-2 + sal), quinpirole (saline WD-2 + Q), or clonidine (saline 
WD-2 + CL). * indicates a significant difference, p < 0.05. 







